AN2 Therapeutics, Inc.
ANTX
$4.27
-$0.45-9.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 58.00M | 61.92M | 62.92M | 67.06M | 83.62M |
| Total Receivables | 900.00K | 600.00K | 400.00K | 300.00K | 300.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.04M | 1.50M | 4.21M | 2.20M | 2.34M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 59.94M | 64.02M | 67.52M | 69.56M | 86.26M |
|
|
|||||
| Total Current Assets | 59.94M | 64.02M | 67.52M | 69.56M | 86.26M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 304.00K | 804.00K |
| Total Assets | 61.95M | 67.24M | 75.83M | 81.34M | 92.09M |
|
|
|||||
| Total Accounts Payable | 3.02M | 2.23M | 2.11M | 3.07M | 3.32M |
| Total Accrued Expenses | 4.47M | 4.45M | 4.15M | 4.57M | 6.13M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.23M | 183.00K | 717.00K | 369.00K | 791.00K |
| Total Other Current Liabilities | 1.23M | 183.00K | 717.00K | 369.00K | 791.00K |
| Total Current Liabilities | 8.72M | 6.86M | 6.98M | 8.01M | 10.24M |
|
|
|||||
| Total Current Liabilities | 8.72M | 6.86M | 6.98M | 8.01M | 10.24M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 170.00K | -- | -- | -- | -- |
| Total Liabilities | 8.89M | 6.86M | 6.98M | 8.01M | 10.24M |
|
|
|||||
| Common Stock & APIC | 293.95M | 292.55M | 291.70M | 289.71M | 287.59M |
| Retained Earnings | -240.95M | -232.24M | -222.89M | -216.43M | -205.78M |
| Treasury Stock & Other | 57.00K | 64.00K | 25.00K | 48.00K | 31.00K |
| Total Common Equity | 53.06M | 60.38M | 68.84M | 73.33M | 81.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 53.06M | 60.38M | 68.84M | 73.33M | 81.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 53.06M | 60.38M | 68.84M | 73.33M | 81.85M |
|
|
|||||